Anecdotal evidence suggests pain sufferers are swapping opioids for medicinal cannabis, but there hasn’t been any solid proof of its effectiveness in weaning patients off the drugs – until now. Rachel Williamson reports.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Emyria and Medlab Clinical are on the cusp of releasing data they say will prove medicinal cannabis has a quantifiable effect on opioid use once and for all.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...